Role of betacellulin in diabetic macular edema
β细胞素在糖尿病黄斑水肿中的作用
基本信息
- 批准号:8449210
- 负责人:
- 金额:$ 37.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-04-01 至 2015-03-31
- 项目状态:已结题
- 来源:
- 关键词:BindingBlindnessBlood VesselsBlood-Retinal BarrierCardiovascular DiseasesCellsCleaved cellComplications of Diabetes MellitusDevelopmentDiabetes MellitusDiabetic RetinopathyDiabetic mouseDisintegrinsEpidemicEpidemiologic StudiesEpidermal Growth FactorExtravasationExudateFamilyFutureHumanHyperglycemiaHyperglycemic MiceHypoglycemiaIncidenceInsulinIntervention StudiesIslet CellLeadLiquid substanceMaintenanceMembraneMetalloproteasesModalityMolecularMorbidity - disease rateNatural regenerationNon-Insulin-Dependent Diabetes MellitusPancreasPathogenesisPathologyPatientsPermeabilityPhysiologicalPlasmaPlayProliferatingReportingRetinaRetinalRetinal DiseasesRetinal HemorrhageRiskRoleSmooth Muscle MyocytesStructure of retinal pigment epitheliumTestingTight JunctionsVascular PermeabilitiesVisionbasebetacellulindiabeticdisorder of macula of retinaglycemic controlhigh riskintravitreal injectionmaculamacular edemamembermortalitypreventproliferative diabetic retinopathypublic health relevanceretina blood vessel structuresolutetherapeutic development
项目摘要
DESCRIPTION (provided by applicant): The incidence of diabetes world-wide, is expected to reach epidemic proportions by 2025. Progression of diabetic retinopathy often results in diabetic macular edema, which is a consequence of the breakdown of the blood-retinal barrier, increased retinal vascular permeability and leakage of plasma from small blood vessels in the macula leading to loss of central vision. The degree of hyperglycemia and duration of diabetes have been shown to be good predictors of retinal complications. Intervention studies have determined that while intensive treatment of diabetes reduced the development of proliferative diabetic retinopathy it was associated with an increased risk of mortality from cardiovascular disease (Ismail-Beigi June 29, 2010 Lancet online) as well as with a higher morbidity risk from hypoglycemic episodes. We reason that it is critical to identify a downstream glycemic target that causes increased retinal vascular permeability that could be targeted therapeutically without the additional risks associated with intensive treatment of the hyperglycemia. Betacellulin is a 32 kD member of the epidermal growth factor family that is produced by proliferating ¿ cells of the islets and promotes regeneration of pancreatic ¿ cells. We hypothesize a role for betacellulin in the retinal vascular complications associated with diabetes based on our preliminary studies, which show that diabetic mice have accentuated retinal vascular permeability with a concomitant increased expression of a cleaved soluble form of betacellulin (s-Btc) in the retina. Intravitreal injection of betacellulin induced retinal hemorrhage and increased vascular permeability in normoglycemic and hyperglycemic mice. A disintegrin and metalloproteinase, ADAM-10 (which plays a role in the cleavage of betacellulin), is increased in the retinae of diabetic mice and humans with diabetic retinopathy. Based on these preliminary results we hypothesize that betacellulin contributes to increased retinal vascular permeability and the pathogenesis of diabetic macular edema.
描述(由申请人提供):到2025年,全球糖尿病的发病率预计将达到流行病的程度。糖尿病视网膜病变的进展通常导致糖尿病性黄斑水肿,这是血视网膜屏障破裂、视网膜血管通透性增加和黄斑小血管血浆渗漏导致中央视力丧失的结果。高血糖程度和糖尿病病程已被证明是视网膜并发症的良好预测指标。干预研究已经确定,虽然糖尿病的强化治疗减少了增殖性糖尿病视网膜病变的发展,但它与心血管疾病死亡风险的增加有关(Ismail-Beigi, 2010年6月29日,柳叶刀在线),以及低血糖发作的发病率风险较高。我们认为,确定导致视网膜血管通透性增加的下游血糖靶标是至关重要的,这种靶标可以靶向治疗,而不会带来与高血糖强化治疗相关的额外风险。Betacellulin是一个32 kD的表皮生长因子家族成员,由胰岛增殖细胞产生并促进胰腺细胞再生。根据我们的初步研究,我们假设β -纤维素蛋白在糖尿病相关的视网膜血管并发症中的作用,这些研究表明,糖尿病小鼠视网膜血管通透性增强,同时视网膜中β -纤维素蛋白(s-Btc)的裂解可溶性形式表达增加。玻璃体内注射β -纤维素蛋白诱导正常血糖和高血糖小鼠视网膜出血和血管通透性增加。一种崩解素和金属蛋白酶ADAM-10(在β细胞蛋白的分裂中起作用)在糖尿病小鼠和糖尿病视网膜病变患者的视网膜中增加。基于这些初步结果,我们假设β细胞素有助于增加视网膜血管通透性和糖尿病黄斑水肿的发病机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BELA ANAND-APTE其他文献
BELA ANAND-APTE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BELA ANAND-APTE', 18)}}的其他基金
Regulation of Choroidal Neovascularization in Sorsby's Fundus Dystrophy
索尔斯比眼底营养不良中脉络膜新生血管的调节
- 批准号:
9900004 - 财政年份:2017
- 资助金额:
$ 37.29万 - 项目类别:
FGF and hyaluronan-mediated alterations in epithelial-mesenchymal transition and metabolism of RPE cells in Sorsby Fundus Dystrophy.
FGF 和透明质酸介导的索斯比眼底营养不良中 RPE 细胞上皮-间质转化和代谢的改变。
- 批准号:
10408757 - 财政年份:2017
- 资助金额:
$ 37.29万 - 项目类别:
FGF and hyaluronan-mediated alterations in epithelial-mesenchymal transition and metabolism of RPE cells in Sorsby Fundus Dystrophy.
FGF 和透明质酸介导的索斯比眼底营养不良中 RPE 细胞上皮-间质转化和代谢的改变。
- 批准号:
10636830 - 财政年份:2017
- 资助金额:
$ 37.29万 - 项目类别:
Role of Retinoic Acid in the Regulation of the Blood-Retinal Barrier.
视黄酸在血视网膜屏障调节中的作用。
- 批准号:
9769753 - 财政年份:2016
- 资助金额:
$ 37.29万 - 项目类别:
Role of Retinoic Acid in the Regulation of the Blood-Retinal Barrier.
视黄酸在血视网膜屏障调节中的作用。
- 批准号:
9334214 - 财政年份:2016
- 资助金额:
$ 37.29万 - 项目类别:
Role of Retinoic Acid in the Regulation of the Blood-Retinal Barrier.
视黄酸在血视网膜屏障调节中的作用。
- 批准号:
10011815 - 财政年份:2016
- 资助金额:
$ 37.29万 - 项目类别:
相似海外基金
Variability of Brain Reorganization in Blindness
失明时大脑重组的变异性
- 批准号:
10562129 - 财政年份:2023
- 资助金额:
$ 37.29万 - 项目类别:
Beyond the Visual: Blindness and Expanded Sculpture
超越视觉:失明与扩展的雕塑
- 批准号:
AH/Y005856/1 - 财政年份:2023
- 资助金额:
$ 37.29万 - 项目类别:
Research Grant
Innovative therapeutic strategies to support elimination of river blindness
支持消除河盲症的创新治疗策略
- 批准号:
10754120 - 财政年份:2023
- 资助金额:
$ 37.29万 - 项目类别:
Anatomical, neural, and computational constraints on sensory cross-modal plasticity following early blindness
早期失明后感觉跨模态可塑性的解剖学、神经学和计算限制
- 批准号:
10570400 - 财政年份:2023
- 资助金额:
$ 37.29万 - 项目类别:
Follow on to: Preventing avoidable blindness through smart home-monitoring of vision
继续:通过智能家居视力监测预防可避免的失明
- 批准号:
ES/Y001346/1 - 财政年份:2023
- 资助金额:
$ 37.29万 - 项目类别:
Research Grant
Establishment of preventive methods for blindness due to pathologic myopia by targeting CCDC102B
以CCDC102B为靶点建立病理性近视致盲预防方法
- 批准号:
23K09009 - 财政年份:2023
- 资助金额:
$ 37.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of neural compensation in the retina and dysfunction in congenital stationary night blindness
先天性静止性夜盲症视网膜神经代偿机制及功能障碍
- 批准号:
10678730 - 财政年份:2023
- 资助金额:
$ 37.29万 - 项目类别:
NSF Convergence Accelerator Track H: Phase II Smart Wearables for Expanding Workplace Access for People with Blindness and Low Vision
NSF 融合加速器轨道 H:第二阶段智能可穿戴设备,扩大失明和低视力人士的工作场所使用范围
- 批准号:
2345139 - 财政年份:2023
- 资助金额:
$ 37.29万 - 项目类别:
Cooperative Agreement
3D bioprinting of regenerative, corneal cell-laden inks to treat corneal blindness
3D 生物打印充满角膜细胞的再生墨水来治疗角膜失明
- 批准号:
10606474 - 财政年份:2023
- 资助金额:
$ 37.29万 - 项目类别:
From 'plant blindness' to 'bug blindness': disseminating an evidence-based pedagogy for plants and refining methodologies in attitudinal research
从“植物盲”到“虫盲”:传播植物循证教育学并完善态度研究方法
- 批准号:
ES/X007324/1 - 财政年份:2022
- 资助金额:
$ 37.29万 - 项目类别:
Fellowship














{{item.name}}会员




